ScoreWhy is FibroGen, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -48.42% and Operating profit at 12.02% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -93.57
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 29.07%, its profits have risen by 61.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is FibroGen, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
FibroGen, Inc.
27.57%
7.72
66.91%
S&P 500
20.78%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-48.42%
EBIT Growth (5y)
12.02%
EBIT to Interest (avg)
-93.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.27
Sales to Capital Employed (avg)
-0.45
Tax Ratio
0.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
50.22%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.89
EV to EBIT
0.94
EV to EBITDA
0.96
EV to Capital Employed
0.43
EV to Sales
-6.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
45.59%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -21.39 MM
NET PROFIT(HY)
Higher at USD -29.73 MM
INVENTORY TURNOVER RATIO(HY)
Highest at 1.48 times
NET SALES(Q)
Highest at USD 3.74 MM
OPERATING PROFIT MARGIN(Q)
Highest at -368.89 %
-4What is not working for the Company
NET SALES(HY)
At USD 5.01 MM has Grown at -14.64%
RAW MATERIAL COST(Y)
Grown by 114.17% (YoY
EPS(Q)
Lowest at USD -3.76
Here's what is working for FibroGen, Inc.
Net Sales
At USD 3.74 MM has Grown at 132.17%
over average net sales of the previous four periods of USD 1.61 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Operating Cash Flow
Highest at USD -21.39 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Profit
Higher at USD -29.73 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Net Sales
Highest at USD 3.74 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -368.89 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Inventory Turnover Ratio
Highest at 1.48 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for FibroGen, Inc.
EPS
Lowest at USD -3.76
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Raw Material Cost
Grown by 114.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
